On (b)(6) 2020, the physician assistant reported an adverse event in a female patient that he injected with bilateral durolane injections for osteoarthritis in the knees in (b)(6) 2020.An unknown amount of time post-injection, she developed injection site pain and skin changes and/or discolorations commensurate with nicolau syndrome.The patient was provided unknown treatment, and her current status is unknown at the time of this report.Based on the information available, the root cause of the reported event is most likely related to a very rare embolic event from the intraarticular cavity to the skin.
|